eMedicine Specialties > Emergency Medicine > Infectious Diseases
Meningitis: Follow-up
Updated: Jul 28, 2009
Follow-up
Further Inpatient Care
- Admit to appropriate service.
- If meningococcal meningitis is suspected, arrange for respiratory isolation for the first 24 hours and ensure appropriate ED personnel receive prophylaxis (see Patient Education).
Deterrence/Prevention
- One vaccine protects against 4 strains of N meningitidis. As of February 2008, the Advisory Committee on Immunization Practices no longer recommends routine immunization of children, but they continue to recommend routine immunization of teenagers and all children/adults at increased risk.7
- It is not known whether the adult use of conjugate pneumococcal vaccine decreases the incidence of S pneumoniae meningitis.
- There is no standard recommendation for H influenzae vaccination in adults.
Complications
- Immediate -Septic shock, including DIC, coma with loss of protective airway reflexes, seizures (30-40% of children, 20-30% of adults), cerebral edema, septic arthritis, pericardial effusion, and hemolytic anemia (H influenzae)
- Subdural effusions - Reported in 39% of children aged 1-18 months with bacterial meningitis
- Risk factors include young age, rapid onset of illness, low peripheral WBC count, and high CSF protein.
- Seizures occur more commonly during the acute course of the disease, although long-term sequelae of promptly treated subdural effusions are similar to those of uncomplicated meningitis.
- Delayed - Decreased hearing or deafness, other cranial nerve dysfunction, multiple seizures, focal paralysis, subdural effusions, hydrocephalus, intellectual deficits, ataxia, blindness, Waterhouse-Friderichsen syndrome, and peripheral gangrene
Prognosis
- Prognosis depends on the pathogen, patient's age and condition, and severity of acute illness.
- Patients with severe neurologic impairment on presentation or with extremely rapid onset of illness, even if treated immediately, have a 50-90% mortality rate and an even higher rate of morbidity.
- Pneumococcal meningitis has the highest rates of mortality (21%) and morbidity (15%).
Patient Education
- Health professionals recommend vaccinating all US college students against N meningitis.
- See Treatment for recommended prophylaxis for close contacts of patient with (suspected) N meningitidis or H influenzae type b meningitis.
- Instruct all contacts to return to ED immediately at the first sign of fever, sore throat, rash, or symptoms of meningitis.
- Rifampin prophylaxis only eradicates the organism from the nasopharynx; it is ineffective against invasive disease.
- For excellent patient education resources, visit eMedicine's Brain and Nervous System Center. Also, see eMedicine's patient education articles Meningitis in Adults and Meningitis in Children.
Miscellaneous
Medicolegal Pitfalls
- Failure to diagnose bacterial meningitis among the top 5 ED malpractice claims
- Failure to promptly institute treatment or failure to educate regarding follow-up care in previously discharged patient
Special Concerns
- Neonate: Query the mother regarding intrapartum antibiotic prophylaxis and, if none, risk factors (eg, delivery <37 wk gestation, ruptured membranes 18 h or more, previously delivered child with group B streptococcal (GBS) infection, GBS bacteruria during pregnancy, intrapartum temp 100.4°F [38°C] or higher).
- Travelers - Elicit recent travel history, as some third world countries have outbreaks of meningococcal epidemics.
- Geriatric patients - Elicit history of pneumococcal immunization.
- Young adults - Routine immunization of this population has been the subject of controversy; however, this group is at greatest risk of exposure to epidemic meningococcal disease.
- Revaccination is not recommended, but some authorities believe a booster may be required for patients at high risk (eg, nephrotic syndromes, renal failure, transplant recipients, splenectomy, HIV with last vaccine >6 y ago).
More on Meningitis |
| Overview: Meningitis |
| Differential Diagnoses & Workup: Meningitis |
| Treatment & Medication: Meningitis |
Follow-up: Meningitis |
| Multimedia: Meningitis |
| References |
| « Previous Page | Next Page » |
References
Scheld WM, Koedel U, Nathan B, Pfister HW. Pathophysiology of bacterial meningitis: mechanism(s) of neuronal injury. J Infect Dis. Dec 1 2002;186 Suppl 2:S225-33. [Medline].
van de Beek D, de Gans J, Tunkel AR, Wijdicks EF. Community-acquired bacterial meningitis in adults. N Engl J Med. Jan 5 2006;354(1):44-53. [Medline].
Thigpen, M, Rosenstein, NE, Whitney, CG. Bacterial meningitis in the United States --1998-2003. Presented at the 43rd Annual Meeting of the Infectious Diseases Society of America, San Francisco, CA. October 2005;65.
Seupaul RA. Evidence-based emergency medicine/rational clinical examination abstract. How do I perform a lumbar puncture and analyze the results to diagnose bacterial meningitis?. Ann Emerg Med. Jul 2007;50(1):85-7. [Medline].
van de Beek D, de Gans J, McIntyre P, Prasad K. Steroids in adults with acute bacterial meningitis: a systematic review. Lancet Infect Dis. Mar 2004;4(3):139-43. [Medline].
Peltola H, Roine I. Improving the outcomes in children with bacterial meningitis. Curr Opin Infect Dis. Apr 14 2009;[Medline].
Report from the Advisory Committee on Immunization Practices (ACIP): decision not to recommend routine vaccination of all children aged 2-10 years with quadrivalent meningococcal conjugate vaccine (MCV4). MMWR Morb Mortal Wkly Rep. May 2 2008;57(17):462-5. [Medline].
Anderson DC, Kozak AJ. Meningitis, encephalitis, and brain abscess. In: Tintinalli JE, ed. Emergency Medicine [book on CD-ROM]. 4th ed. McGraw-Hill; 1977:chap 199.
Ashwal S. Neurologic evaluation of the patient with acute bacterial meningitis. Neurol Clin. Aug 1995;13(3):549-77. [Medline].
Barkin R. Meningitis, bacterial. In: Barkin R, ed. Pediatric Emergency Medicine [book on CD-ROM]. 2nd ed. 1992:chap 52.
Beckham JD, Tyler KL. Initial management of acute bacterial meningitis in adults: summary of IDSA guidelines. Rev Neurol Dis. Spring 2006;3(2):57-60. [Medline].
de Gans J, van de Beek D,. Dexamethasone in adults with bacterial meningitis. N Engl J Med. Nov 14 2002;347(20):1549-56. [Medline].
Fitch MT, van de Beek D. Emergency diagnosis and treatment of adult meningitis. Lancet Infect Dis. Mar 2007;7(3):191-200. [Medline].
Kelley J, ed. Approach to the patient with suspected central nervous system infections. In: Textbook of Internal Medicine [book on CD-ROM]. 3rd ed. Lippincott-Raven; 1996:chap 435.
Kelley J, ed. Meningitis and ventriculitis. In: Textbook of Internal Medicine [book on CD-ROM]. 3rd ed. Lippincott-Raven; 1996:chap 446.
McIntyre PB, Berkey CS, King SM, et al. Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988. JAMA. Sep 17 1997;278(11):925-31. [Medline].
Mellis P. Bacteria, sepsis, and meningitis in children. In: Tintinalli JE, ed. Emergency Medicine [book on CD-ROM]. 4th ed. McGraw-Hill; 1997:chap 109.
Miller LG, Choi C. Meningitis in older patients: how to diagnose and treat a deadly infection. Geriatrics. Aug 1997;52(8):43-4, 47-50, 55. [Medline].
Pfister HW, Scheld WM. Brain injury in bacterial meningitis: therapeutic implications. Curr Opin Neurol. Jun 1997;10(3):254-9. [Medline].
Pomar V, Martinez S, Paredes R, Domingo P. Advances in adjuvant therapy against acute bacterial meningitis. Curr Drug Targets Infect Disord. Dec 2004;4(4):303-9. [Medline].
Powderly WG. Cryptococcal meningitis and AIDS. Clin Infect Dis. Nov 1993;17(5):837-42. [Medline].
Prasad K, Singhal T, Jain N, Gupta PK. Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis. Cochrane Database Syst Rev. 2004;CD001832. [Medline].
Quagliarello VJ, Scheld WM. Treatment of bacterial meningitis. N Engl J Med. Mar 6 1997;336(10):708-16. [Medline].
Rosenstein N, Levine O, Taylor JP, et al. Efficacy of meningococcal vaccine and barriers to vaccination. JAMA. Feb 11 1998;279(6):435-9. [Medline].
Schaad UB, Kaplan SL, McCracken GH. Steroid therapy for bacterial meningitis. Clin Infect Dis. Mar 1995;20(3):685-90. [Medline].
Sinner SW, Tunkel AR. Antimicrobial agents in the treatment of bacterial meningitis. Infect Dis Clin North Am. Sep 2004;18(3):581-602, ix. [Medline].
[Guideline] Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. Nov 1 2004;39(9):1267-84. [Medline].
Walls RM. Adult meningitis, encephalitis, and intracranial abscess. In: Rosen P, ed. Emergency Medicine [book on CD-ROM]. 3rd ed. Mosby; 1992:chap 94.
Further Reading
Keywords
inflammation of the leptomeninges, inflammation of the underlying subarachnoid cerebrospinal fluid, bacterial meningitis, meningococcal meningitis, pneumococcal meningitis, Neisseria meningitidis, N meningitidis, Streptococcus pneumoniae, S pneumoniae, Listeria monocytogenes, L monocytogenes, group B streptococci, Haemophilus influenzae, H influenzae , Haemophilus influenzae type b, H influenzae type b, brain edema, nuchal rigidity, fungalmeningitis, tuberculous meningitis, Kernig sign, Brudzinski sign, papilledema, increased intracranial pressure, increased ICP
Follow-up: Meningitis